Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
FAA proposes fine of $1.25M on Boeing over factory actions, Reuters says » 17:20
08/05/20
08/05
17:20
08/05/20
17:20
BA

Boeing

$174.32 /

+9.3 (+5.64%)

The Federal Aviation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BA Boeing
$174.32 /

+9.3 (+5.64%)

BA Boeing
$174.32 /

+9.3 (+5.64%)

07/30/20 RBC Capital
Boeing price target raised to $194 from $164 at RBC Capital
07/30/20 Susquehanna
Boeing price target lowered to $210 from $240 at Susquehanna
07/30/20 Goldman Sachs
Boeing Q2 low point for cancellations and deliveries, says Goldman Sachs
07/20/20 Canaccord
Boeing monetary stimulus supports stock, says Canaccord
BA Boeing
$174.32 /

+9.3 (+5.64%)

BA Boeing
$174.32 /

+9.3 (+5.64%)

BA Boeing
$174.32 /

+9.3 (+5.64%)

BA Boeing
$174.32 /

+9.3 (+5.64%)

Yesterday
Recommendations
Merck deal sparks interest in GLP-1:glucagon agonists, says Piper Sandler » 15:18
08/04/20
08/04
15:18
08/04/20
15:18
ALT

Altimmune

$28.22 /

+1.06 (+3.90%)

, MRK

Merck

$81.25 /

-1.3 (-1.57%)

Merck (MRK) and Hanmi…

Merck (MRK) and Hanmi Pharma this morning entered into an agreement for Merck to license efinopegdutide, a GLP-1:glucagon agonist, for development in nonalcoholic steatohepatitis, Piper Sandler analyst Yasmeen Rahimi tells investors in a research note. With only a $10M upfront payment for Hanmi's asset, there is a "strong rationale" for Altimmune's (ALT) GLP-1:glucagon agonist ALT-801, which is expected to start Phase 1 testing in Q4, to bring a cleaner gastrointestinal tolerability profile, says the analyst. Large pharma interest in dual GLP-1:glucagon agonists validates the mechanism of action in NASH, and ALT-801's therapeutic has a potentially higher value than efinopegdutide, contends Rahimi. The analyst keeps an Overweight rating on Altimmune with an $80 price target.

ShowHide Related Items >><<
MRK Merck
$81.25 /

-1.3 (-1.57%)

ALT Altimmune
$28.22 /

+1.06 (+3.90%)

ALT Altimmune
$28.22 /

+1.06 (+3.90%)

07/31/20
Fly Intel: Top five analyst initiations
07/30/20 Piper Sandler
Altimmune initiated with an Overweight at Piper Sandler
07/28/20 JMP Securities
Altimmune initiated with an Outperform at JMP Securities
06/01/20 Roth Capital
Altimmune surprises with differentiated T-COVID study, says Roth Capital
MRK Merck
$81.25 /

-1.3 (-1.57%)

08/03/20
Fly Intel: Top five analyst upgrades
08/03/20 Goldman Sachs
Merck upgraded to Buy from Neutral at Goldman Sachs
07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/27/20 H.C. Wainwright
Agreement termination 'optimal' for Vyleesi future, says H.C. Wainwright
MRK Merck
$81.25 /

-1.3 (-1.57%)

ALT Altimmune
$28.22 /

+1.06 (+3.90%)

  • 14
    Jul
MRK Merck
$81.25 /

-1.3 (-1.57%)

MRK Merck
$81.25 /

-1.3 (-1.57%)

ALT Altimmune
$28.22 /

+1.06 (+3.90%)

MRK Merck
$81.25 /

-1.3 (-1.57%)

ALT Altimmune
$28.22 /

+1.06 (+3.90%)

Monday
Syndicate
Boeing files automatic mixed securities shelf  16:35
08/03/20
08/03
16:35
08/03/20
16:35
BA

Boeing

$162.25 /

+4.29 (+2.72%)

 
ShowHide Related Items >><<
BA Boeing
$162.25 /

+4.29 (+2.72%)

BA Boeing
$162.25 /

+4.29 (+2.72%)

07/30/20 RBC Capital
Boeing price target raised to $194 from $164 at RBC Capital
07/30/20 Susquehanna
Boeing price target lowered to $210 from $240 at Susquehanna
07/30/20 Goldman Sachs
Boeing Q2 low point for cancellations and deliveries, says Goldman Sachs
07/20/20 Canaccord
Boeing monetary stimulus supports stock, says Canaccord
BA Boeing
$162.25 /

+4.29 (+2.72%)

BA Boeing
$162.25 /

+4.29 (+2.72%)

BA Boeing
$162.25 /

+4.29 (+2.72%)

BA Boeing
$162.25 /

+4.29 (+2.72%)

Hot Stocks
FAA says notice of proposed rulemaking for Boeing 737 MAX directive available » 14:36
08/03/20
08/03
14:36
08/03/20
14:36
BA

Boeing

$161.46 /

+3.5 (+2.22%)

The Federal Aviation…

The Federal Aviation Administration announced that it has sent a notice of proposed rulemaking for a Boeing 737 MAX airworthiness directive to the Office of the Federal Register for publication. "The NPRM proposes mandating a number of design changes to address an identified unsafe condition. When the NPRM publishes in the Federal Register, a 45 day public comment period will begin. The FAA is posting the NPRM on its website today to enable the public to begin review early. The FAA will also be placing the Preliminary Summary of the FAA's Review of the Boeing 737 MAX in the docket to assist with the review of the proposed AD," the FAA announced on its website. Reference Link

ShowHide Related Items >><<
BA Boeing
$161.46 /

+3.5 (+2.22%)

BA Boeing
$161.46 /

+3.5 (+2.22%)

07/30/20 RBC Capital
Boeing price target raised to $194 from $164 at RBC Capital
07/30/20 Susquehanna
Boeing price target lowered to $210 from $240 at Susquehanna
07/30/20 Goldman Sachs
Boeing Q2 low point for cancellations and deliveries, says Goldman Sachs
07/20/20 Canaccord
Boeing monetary stimulus supports stock, says Canaccord
BA Boeing
$161.46 /

+3.5 (+2.22%)

BA Boeing
$161.46 /

+3.5 (+2.22%)

BA Boeing
$161.46 /

+3.5 (+2.22%)

BA Boeing
$161.46 /

+3.5 (+2.22%)

Hot Stocks
FAA announces NPRM for Boeing 737 MAX airworthiness directive  14:34
08/03/20
08/03
14:34
08/03/20
14:34
BA

Boeing

$161.39 /

+3.43 (+2.17%)

 
ShowHide Related Items >><<
BA Boeing
$161.39 /

+3.43 (+2.17%)

BA Boeing
$161.39 /

+3.43 (+2.17%)

07/30/20 RBC Capital
Boeing price target raised to $194 from $164 at RBC Capital
07/30/20 Susquehanna
Boeing price target lowered to $210 from $240 at Susquehanna
07/30/20 Goldman Sachs
Boeing Q2 low point for cancellations and deliveries, says Goldman Sachs
07/20/20 Canaccord
Boeing monetary stimulus supports stock, says Canaccord
BA Boeing
$161.39 /

+3.43 (+2.17%)

BA Boeing
$161.39 /

+3.43 (+2.17%)

BA Boeing
$161.39 /

+3.43 (+2.17%)

BA Boeing
$161.39 /

+3.43 (+2.17%)

Hot Stocks
Triumph Group to sell composites operations to Arlington Capital Partners » 09:05
08/03/20
08/03
09:05
08/03/20
09:05
TGI

Triumph Group

$6.77 /

+0.105 (+1.58%)

, BA

Boeing

$157.96 /

-3.93 (-2.43%)

, EADSY

Airbus

$0.00 /

+ (+0.00%)

, ERJ

Embraer

$5.79 /

-0.33 (-5.40%)

, NOC

Northrop Grumman

$325.42 /

-0.62 (-0.19%)

Triumph Group (TGI)…

Triumph Group (TGI) announced a definitive agreement to sell its composites operations to Arlington Capital Partners. Included in the sale are the Triumph Aerospace Structures composites locations in Milledgeville, Georgia and Rayong, Thailand. The operations cover approximately 800 thousand square feet of factory space and employ approximately 600 people. The composites business provides structural and engine composite fabrications and assemblies across commercial, business jet, and defense platforms. Key programs supported by the sites include Boeing (BA) 787, 777 and V-22, Airbus (EADSY) A320, A330 and A350, Embraer (ERJ) E-2, Northrop Grumman (NOC) Global Hawk, as well as the Gulfstream G650/700. The transaction is subject to customary closing conditions and is expected to close in Triumph's second quarter of FY21. Following the close of the transaction, the business will retain its management, technical and supporting staff, and will continue operations at the current facilities.

ShowHide Related Items >><<
TGI Triumph Group
$6.77 /

+0.105 (+1.58%)

NOC Northrop Grumman
$325.42 /

-0.62 (-0.19%)

ERJ Embraer
$5.79 /

-0.33 (-5.40%)

EADSY Airbus
$0.00 /

+ (+0.00%)

BA Boeing
$157.96 /

-3.93 (-2.43%)

TGI Triumph Group
$6.77 /

+0.105 (+1.58%)

07/15/20 Truist
SunTrust downgrades select commercial aviation supply stocks
07/15/20 Truist
Triumph Group downgraded to Sell from Hold at SunTrust
03/20/20 BofA
BofA double downgrades Triumph, slashes price target amid COVID-19 impact
03/20/20 BofA
Triumph Group downgraded to Underperform from Buy at BofA
BA Boeing
$157.96 /

-3.93 (-2.43%)

07/30/20 RBC Capital
Boeing price target raised to $194 from $164 at RBC Capital
07/30/20 Susquehanna
Boeing price target lowered to $210 from $240 at Susquehanna
07/30/20 Goldman Sachs
Boeing Q2 low point for cancellations and deliveries, says Goldman Sachs
07/20/20 Canaccord
Boeing monetary stimulus supports stock, says Canaccord
EADSY Airbus
$0.00 /

+ (+0.00%)

07/31/20 Barclays
Airbus price target raised to EUR 71 from EUR 69 at Barclays
07/27/20 JPMorgan
Airbus price target raised to EUR 54 from EUR 51 at JPMorgan
07/20/20 UBS
Airbus price target raised to EUR 103 from EUR 100 at UBS
07/16/20 Morgan Stanley
Airbus price target lowered to EUR 90 from EUR 94 at Morgan Stanley
ERJ Embraer
$5.79 /

-0.33 (-5.40%)

05/04/20 BofA
Embraer downgraded to Neutral from Buy at BofA
04/28/20 Credit Suisse
Embraer downgraded to Underperform from Neutral at Credit Suisse
04/27/20 Bradesco BBI
Embraer downgraded to Underperform from Outperform at Bradesco
04/09/20
Fly Intel: Top five analyst upgrades
NOC Northrop Grumman
$325.42 /

-0.62 (-0.19%)

07/31/20 RBC Capital
Northrop Grumman price target raised to $391 from $366 at RBC Capital
07/31/20 Bernstein
Northrop Grumman price target raised to $419 from $405 at Bernstein
05/20/20 RBC Capital
Northrop Grumman initiated with Sector Perform on valuation at RBC Capital
05/20/20 RBC Capital
Northrop Grumman initiated with a Sector Perform at RBC Capital
TGI Triumph Group
$6.77 /

+0.105 (+1.58%)

NOC Northrop Grumman
$325.42 /

-0.62 (-0.19%)

ERJ Embraer
$5.79 /

-0.33 (-5.40%)

EADSY Airbus
$0.00 /

+ (+0.00%)

BA Boeing
$157.96 /

-3.93 (-2.43%)

ERJ Embraer
$5.79 /

-0.33 (-5.40%)

EADSY Airbus
$0.00 /

+ (+0.00%)

BA Boeing
$157.96 /

-3.93 (-2.43%)

TGI Triumph Group
$6.77 /

+0.105 (+1.58%)

NOC Northrop Grumman
$325.42 /

-0.62 (-0.19%)

ERJ Embraer
$5.79 /

-0.33 (-5.40%)

EADSY Airbus
$0.00 /

+ (+0.00%)

BA Boeing
$157.96 /

-3.93 (-2.43%)

BA Boeing
$157.96 /

-3.93 (-2.43%)

Hot Stocks
Vanda Pharmaceuticals: FDA grants priority review of applications for HETLIOZ » 07:02
08/03/20
08/03
07:02
08/03/20
07:02
VNDA

Vanda Pharmaceuticals

$10.09 /

-0.225 (-2.18%)

Vanda Pharmaceuticals…

Vanda Pharmaceuticals announced that the U.S. FDA has accepted for priority review Vanda's applications for Smith-Magenis Syndrome. The applications include a Supplemental New Drug Application for HETLIOZ capsules and a New Drug Application for the liquid formulation of HETLIOZ for the treatment of adults and children, respectively, with Smith-Magenis Syndrome. The FDA has set December 1, 2020 as the target date for its decision under the Prescription Drug User Fee Act.

ShowHide Related Items >><<
VNDA Vanda Pharmaceuticals
$10.09 /

-0.225 (-2.18%)

VNDA Vanda Pharmaceuticals
$10.09 /

-0.225 (-2.18%)

06/09/20 Citi
Vanda downgraded to Neutral on FDA dispute at Citi
06/09/20 Citi
Vanda Pharmaceuticals downgraded to Neutral from Buy at Citi
03/16/20
Fly Intel: Top five analyst downgrades
03/16/20 Oppenheimer
Vanda Pharmaceuticals downgraded to Underperform at Oppenheimer on Hetlioz risks
VNDA Vanda Pharmaceuticals
$10.09 /

-0.225 (-2.18%)

VNDA Vanda Pharmaceuticals
$10.09 /

-0.225 (-2.18%)

Friday
Hot Stocks
Spirit Aero to reduce headcount on commercial programs by 1,100 workers » 17:58
07/31/20
07/31
17:58
07/31/20
17:58
SPR

Spirit AeroSystems

$19.55 /

-0.775 (-3.81%)

, BA

Boeing

$157.96 /

-3.93 (-2.43%)

Spirit AeroSystems (SPR)…

Spirit AeroSystems (SPR) announced it will further reduce employment at its facility in Wichita, Kan., as a result of the most recent rate reduction on the 737 MAX (BA) and the ongoing global pandemic, which continue to impact the demand for new commercial aircraft and the airline industry as a whole. "Our production rates for commercial aircraft have fallen from historic highs to significantly lower volumes in a matter of months," said Tom Gentile, President and CEO, Spirit AeroSystems. "We are taking this action to better calibrate our employment level to the reduced demand we see from our customers. This action, along with previous actions, is intended to reduce costs, increase liquidity and position Spirit to remain financially healthy while we move through a period of recovery in the commercial aviation market." The 737 MAX production rate reduction is the third this year, lowering Spirit's production from 125 units to 72 units for 2020, a reduction of more than 80 percent from its 2019 production rates. To support the alignment of workforce levels with the customer demand for aircraft, Spirit will reduce headcount on commercial programs by 1,100 employees. This announcement represents 450 new layoffs at the Wichita site when taking into account prior layoff notifications and employees transitioning to defense programs, moving to the temporary special project to build ventilators or electing to participate in the voluntary layoff opportunity.

ShowHide Related Items >><<
SPR Spirit AeroSystems
$19.55 /

-0.775 (-3.81%)

BA Boeing
$157.96 /

-3.93 (-2.43%)

SPR Spirit AeroSystems
$19.55 /

-0.775 (-3.81%)

07/08/20 Bernstein
Bernstein downgrades Spirit AeroSystems on slower delivery recovery
07/08/20 Bernstein
Spirit AeroSystems downgraded to Market Perform from Outperform at Bernstein
06/26/20 RBC Capital
Spirit AeroSystems initiated with an Outperform at RBC Capital
06/23/20
Fly Intel: Top five analyst downgrades
BA Boeing
$157.96 /

-3.93 (-2.43%)

07/30/20 RBC Capital
Boeing price target raised to $194 from $164 at RBC Capital
07/30/20 Susquehanna
Boeing price target lowered to $210 from $240 at Susquehanna
07/30/20 Goldman Sachs
Boeing Q2 low point for cancellations and deliveries, says Goldman Sachs
07/20/20 Canaccord
Boeing monetary stimulus supports stock, says Canaccord
SPR Spirit AeroSystems
$19.55 /

-0.775 (-3.81%)

BA Boeing
$157.96 /

-3.93 (-2.43%)

SPR Spirit AeroSystems
$19.55 /

-0.775 (-3.81%)

BA Boeing
$157.96 /

-3.93 (-2.43%)

SPR Spirit AeroSystems
$19.55 /

-0.775 (-3.81%)

BA Boeing
$157.96 /

-3.93 (-2.43%)

SPR Spirit AeroSystems
$19.55 /

-0.775 (-3.81%)

BA Boeing
$157.96 /

-3.93 (-2.43%)

Hot Stocks
Boeing awarded $265.02M USSOCOM contract modification » 17:18
07/31/20
07/31
17:18
07/31/20
17:18
BA

Boeing

$157.96 /

-3.93 (-2.43%)

Boeing was awarded a…

Boeing was awarded a $265.02M firm-fixed-price, delivery order contract modification to a contract for the procurement of nine MH-47G Chinook aircraft in support of U.S. Special Operations Command, or USSOCOM. This modification raises the contract ceiling to $285M. FY20 procurement funds in the amount of $265.02M are being obligated at the time of award. The majority of the work will be performed in Ridley Park and is expected to be completed February 2023. This contract is a non-competitive award and is in accordance with Federal Acquisition Regulation 6.302.1. USSOCOM is the contracting activity.

ShowHide Related Items >><<
BA Boeing
$157.96 /

-3.93 (-2.43%)

BA Boeing
$157.96 /

-3.93 (-2.43%)

07/30/20 RBC Capital
Boeing price target raised to $194 from $164 at RBC Capital
07/30/20 Susquehanna
Boeing price target lowered to $210 from $240 at Susquehanna
07/30/20 Goldman Sachs
Boeing Q2 low point for cancellations and deliveries, says Goldman Sachs
07/20/20 Canaccord
Boeing monetary stimulus supports stock, says Canaccord
BA Boeing
$157.96 /

-3.93 (-2.43%)

BA Boeing
$157.96 /

-3.93 (-2.43%)

BA Boeing
$157.96 /

-3.93 (-2.43%)

BA Boeing
$157.96 /

-3.93 (-2.43%)

Hot Stocks
Boeing submits response to the Future Fighter Capability Project RFP » 12:32
07/31/20
07/31
12:32
07/31/20
12:32
BA

Boeing

$158.07 /

-3.82 (-2.36%)

Boeing announced that the…

Boeing announced that the Super Hornet response for the Future Fighter Capability Project was submitted on Tuesday, July 28. The company said, "The F/A-18 Super Hornet Block III is a proven, affordable choice for the Royal Canadian Air Force and one that would bring unparalleled, guaranteed opportunities to Canadian industry from coast to coast."

ShowHide Related Items >><<
BA Boeing
$158.07 /

-3.82 (-2.36%)

BA Boeing
$158.07 /

-3.82 (-2.36%)

07/30/20 RBC Capital
Boeing price target raised to $194 from $164 at RBC Capital
07/30/20 Susquehanna
Boeing price target lowered to $210 from $240 at Susquehanna
07/30/20 Goldman Sachs
Boeing Q2 low point for cancellations and deliveries, says Goldman Sachs
07/20/20 Canaccord
Boeing monetary stimulus supports stock, says Canaccord
BA Boeing
$158.07 /

-3.82 (-2.36%)

BA Boeing
$158.07 /

-3.82 (-2.36%)

BA Boeing
$158.07 /

-3.82 (-2.36%)

BA Boeing
$158.07 /

-3.82 (-2.36%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.